Skip to main content
SpringerLink
Log in

Insulin-Like Effects of Visfatin on Human Osteoblasts

Calcified Tissue International volume 80, pages 201–210 (2007)Cite this article

Abstract

Visfatin (also known as pre-B cell colony-enhancing factor or PBEF) is a novel adipocytokine that is highly expressed in visceral fat and upregulated in obesity and type 2 diabetes mellitus. Visfatin binds to and activates the insulin receptor (IR), thereby exerting insulin-mimetic effects in various cell lines. IR has been detected in osteoblasts, which is consistent with the role of insulin as an important osteotropic hormone. This study investigated the actions of visfatin on human primary osteoblasts. The expression and tyrosine phosphorylation of IR, IR substrate-1 (IRS-1), and IRS-2 were determined by immunoprecipitation and immunoblotting. Cell proliferation was determined by measuring [3H]thymidine incorporation and cell number. Glucose uptake was determined by measuring 2-[3H]deoxyglucose incorporation. Real-time quantitative reverse-transcription polymerase chain reaction (PCR) was used for determining alkaline phosphatase (ALP), osteocalcin, and type I collagen mRNA expression. Enzyme-linked immunosorbent assay and radioimmunoassay were used for measuring ALP activity, osteocalcin secretion, and type I collagen production. We found that visfatin induced tyrosine phosphorylation of IR, IRS-1, and IRS-2. Moreover, the effects of visfatin – glucose uptake, proliferation, and type I collagen enhancement of cultured human osteoblast-like cells – bore a close resemblance to those of insulin and were inhibited by hydroxy-2-naphthalenylmethylphosphonic acid tris-acetoxymethyl ester, a specific inhibitor of IR tyrosine kinase activity. We also unexpectedly found that visfatin downregulated osteocalcin secretion from human osteoblast-like cells. These data indicate that the regulation of glucose uptake, proliferation, and type I collagen production by visfatin in human osteoblasts involves IR phosphorylation, the same signal-transduction pathway used by insulin.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.

References

  1. Stewart KJ, Deregis RJ, Turner KL, Bacher AC, Sung J, Hees PS, Tayback M, Ouyang P (2002) Fitness, fatness and activity as predictors of bone mineral density in older persons. J Intern Med 252:381–388

    Article  PubMed  CAS  Google Scholar 

  2. Lim S, Joung H, Shin CS, Lee HK, Kim KS, Shin EK, Kim HY, Lim MK, Cho SI (2004) Body composition changes with age have gender-specific impacts on bone mineral density. Bone 35:792–798

    Article  PubMed  Google Scholar 

  3. Lindsay R, Cosman F, Herrington BS, Himmelstein S (1992) Bone mass and body composition in normal women. J Bone Miner Res 7:55–62

    PubMed  CAS  Google Scholar 

  4. Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight, and body mass index on bone mineral density in men and women. J Bone Miner Res 8:567–573

    PubMed  CAS  Google Scholar 

  5. Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES (1995) Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118–1123

    Article  PubMed  CAS  Google Scholar 

  6. Khosla S, Atkinson EJ, Riggs BL, Melton LJ (1996) Relationship between body composition and bone mass in women. J Bone Miner Res 11:857–863

    PubMed  CAS  Google Scholar 

  7. Schwartz AV (2003) Diabetes mellitus: does it affect bone? Calcif Tissue Int 73:515–519

    Article  PubMed  CAS  Google Scholar 

  8. Dominguez LJ, Muratore M, Quarta E, Zagone G, Barbagallo M (2004) Osteoporosis and diabetes. Reumatismo 56:235–241

    PubMed  CAS  Google Scholar 

  9. Kwon DJ, Kim JH, Chung KW, Kim JH, Lee JW, Kim SP, Lee HY (1996) Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. J Obstet Gynaecol Res 22:157–162

    PubMed  CAS  Google Scholar 

  10. de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16:1713–1720

    Article  PubMed  Google Scholar 

  11. Akin O, Gol K, Akturk M, Erkaya S (2003) Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 17:19–29

    PubMed  CAS  Google Scholar 

  12. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430

    Article  PubMed  CAS  Google Scholar 

  13. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M, Bluher M (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54:2911–2916

    Article  PubMed  CAS  Google Scholar 

  14. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91:1578–1581

    Article  PubMed  CAS  Google Scholar 

  15. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91:295–299

    Article  PubMed  CAS  Google Scholar 

  16. Thomas DM, Hards DK, Rogers SD, Ng KW, Best JD (1996) Insulin receptor expression in bone. J Bone Miner Res 11:1312–1320

    PubMed  CAS  Google Scholar 

  17. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289:E735–E745

    Article  PubMed  CAS  Google Scholar 

  18. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, Skinner RA, Hogue WR, Carver AA, Fowlkes JL, Aronson J, Lumpkin CK Jr (2005) Bone formation is impaired in a model of type 1 diabetes. Diabetes 54:2875–2881

    Article  PubMed  CAS  Google Scholar 

  19. Stolk RP, Van Daele PL, Pols HA, Burger H, Hofman A, Birkenhager JC, Lamberts SW, Grobbee DE (1996) Hyperinsulinemia and bone mineral density in an elderly population: the Rotterdam Study. Bone 18:545–549

    Article  PubMed  CAS  Google Scholar 

  20. Cornish J, Callon KE, Reid IR (1996) Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int 59:492–495

    PubMed  CAS  Google Scholar 

  21. Kasuga M, Hedo JA, Yamada KM, Kahn CR (1982) The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000 possible proreceptor. J Biol Chem 257:10392–10399

    PubMed  CAS  Google Scholar 

  22. Chang L, Chiang SH, Saltiel AR (2004) Insulin signaling and the regulation of glucose transport. Mol Med 10:65–71

    PubMed  CAS  Google Scholar 

  23. Robey PG, Termine JD (1985) Human bone cells in vitro. Calcif Tissue Int 37:453–460

    Article  PubMed  CAS  Google Scholar 

  24. Xie H, Tang SY, Cui RR, Huang J, Ren XH, Yuan LQ, Lu Y, Yang M, Zhou HD, Wu XP, Luo XH, Liao EY (2006) Apelin and its receptor are expressed in human osteoblasts. Regul Pept 134:118–125

    Article  PubMed  CAS  Google Scholar 

  25. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309:99–109

    Article  PubMed  CAS  Google Scholar 

  26. Bodine PV, Trailsmith M, Komm BS (1996) Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res 11:806–819

    PubMed  CAS  Google Scholar 

  27. White MF (2003) Insulin signaling in health and disease. Science 302:1710–1711

    Article  PubMed  CAS  Google Scholar 

  28. Pawson T, Scott JD (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075–2080

    Article  PubMed  CAS  Google Scholar 

  29. Kotani K, Wilden P, Pillay TS (1998) SH2 Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem J 335:103–109

    PubMed  CAS  Google Scholar 

  30. Dong X, Park S, Lin X, Copps K, Yi X, White MF (2006) Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest 116:101–114

    Article  PubMed  CAS  Google Scholar 

  31. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 105:199–205

    Article  PubMed  CAS  Google Scholar 

  32. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904

    Article  PubMed  CAS  Google Scholar 

  33. Ituarte EA, Halstead LR, Iida-Klein A, Ituarte HG, Hahn TJ (1989) Glucose transport system in UMR-106–01 osteoblastic osteosarcoma cells: regulation by insulin. Calcif Tissue Int 45:27–33

    Article  PubMed  CAS  Google Scholar 

  34. Hahn TJ, Westbrook SL, Sullivan TL, Goodman WG, Halstead LR (1988) Glucose transport in osteoblast-enriched bone explants: characterization and insulin regulation J Bone Miner Res 3:359–365

    PubMed  CAS  Google Scholar 

  35. Qutob S, Dixon SJ, Wilson JX (1998) Insulin stimulates vitamin C recycling and ascorbate accumulation in osteoblastic cells. Endocrinology 139:51–56

    Article  PubMed  CAS  Google Scholar 

  36. Thomas DM, Rogers SD, Sleeman MW, Pasquini GM, Bringhurst FR, Ng KW, Zajac JD, Best JD (1995) Modulation of glucose transport by parathyroid hormone and insulin in UMR 106–01, a clonal rat osteogenic sarcoma cell line. J Mol Endocrinol 14:263–275

    Article  PubMed  CAS  Google Scholar 

  37. Hickman J, McElduff A (1989) Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106–01: an osteoblast-like cell. Endocrinology 124:701–706

    PubMed  CAS  Google Scholar 

  38. Craig RG, Rowe DW, Petersen DN, Kream BE (1989) Insulin increases the steady state level of alpha-1(I) procollagen mRNA in the osteoblast-rich segment of fetal rat calvaria. Endocrinology 125:1430–1437

    Article  PubMed  CAS  Google Scholar 

  39. Kim SJ, Chun JY, Kim MS (2000) Insulin stimulates production of nitric oxide via ERK in osteoblast cells. Biochem Biophys Res Commun 278:712–718

    Article  PubMed  CAS  Google Scholar 

  40. Pun KK, Lau P, Ho PW (1989) The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. J Bone Miner Res 4:853–862

    Article  PubMed  CAS  Google Scholar 

  41. Kream B, Harrison J, Bailey R, Petersen D, Rowe D, Lichtler A (1989) Hormonal regulation of collagen gene expression in osteoblastic cell – overview and new findings. Connect Tissue Res 20:187–192

    PubMed  CAS  Google Scholar 

  42. Kream BE, Smith MD, Canalis E, Raisz LG (1985) Characterization of the effect of insulin on collagen synthesis in fetal rat bone. Endocrinology 116:296–302

    PubMed  CAS  Google Scholar 

  43. Rosen DM, Luben RA (1983) Multiple hormonal mechanisms for the control of collagen synthesis in an osteoblast-like cell line, MMB-1. Endocrinology 112:992–999

    PubMed  CAS  Google Scholar 

  44. Sasaki T, Haneda K (1991) Insulin deficiency impairs procollagen synthesis in osteoblasts and periodontal ligament fibroblasts. Showa Shigakkai Zasshi 11:28–37

    PubMed  CAS  Google Scholar 

  45. Rubinacci A, Boniforti F, Tessari L (1991) Effect of insulin on the activity of bone alkaline phosphatase in culture. Minerva Endocrinol 16:187–191

    PubMed  CAS  Google Scholar 

  46. Owen M (1988) Marrow stromal stem cells. J Cell Sci 10:63–76

    CAS  Google Scholar 

  47. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by grants 30200322, 30572078, 30600661 and 30400218 from the China National Natural Scientific Foundation, a Foundation for the Author of National Excellent Doctoral Dissertation of P.R. China (200259), and the Hunan Provincial Outstanding Youth Foundation of P.R. China (03JJY1005).

Author information

Authors and Affiliations

  1. Institute of Endocrinology and Metabolism, Second Xiangya Hospital of Central South University, 139 Middle Renmin Road, Changsha, Hunan, 410011, People’s Republic of China

    H. Xie, S.-Y. Tang, X.-H. Luo, J. Huang, R.-R. Cui, L.-Q. Yuan, H.-D. Zhou, X.-P. Wu & E.-Y. Liao

  2. School of Nursing, Central South University, 172 Tongzipo Road, Changsha, Hunan, 410013, People’s Republic of China

    S.-Y. Tang

Authors
  1. H. Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S.-Y. Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X.-H. Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R.-R. Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L.-Q. Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H.-D. Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. X.-P. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E.-Y. Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E.-Y. Liao.

Additional information

H. Xie and S.-Y. Tang, X.-H. Luo1 contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Xie, H., Tang, SY., Luo, XH. et al. Insulin-Like Effects of Visfatin on Human Osteoblasts. Calcif Tissue Int 80, 201–210 (2007). https://doi.org/10.1007/s00223-006-0155-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-006-0155-7

Keywords

search

Navigation